The olfactory bulb is a critical neural structure located in the anterior forebrain that processes sensory information from the nasal cavity. It is uniquely positioned as a gateway between the peripheral nervous system and the central nervous system, making it particularly vulnerable to neurodegenerative processes[1].
Olfactory dysfunction is now recognized as one of the earliest biomarkers of neurodegenerative disease, often preceding motor and cognitive symptoms by 5-10 years in conditions like Parkinson's disease (PD) and Alzheimer's disease (AD)[2].
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000626 | olfactory granule cell |
The olfactory bulb contains several specialized neuronal populations:
The olfactory bulb performs initial processing of odor information:
The olfactory bulb is one of the earliest sites of alpha-synuclein pathology in PD[3]:
The progression of Lewy body pathology follows a proposed caudo-rostral pattern, with the olfactory bulb affected early in the disease process.
Olfactory involvement in AD includes[4]:
Olfactory testing shows promise for early neurodegenerative disease detection[5]:
| Test | Sensitivity | Specificity | Notes |
|---|---|---|---|
| UPSIT | 80-90% | 70-85% | University of Pennsylvania Smell Identification Test |
| Sniffin' Sticks | 75-85% | 70-80% | Extended test with threshold, discrimination, identification |
| UPSIT + DaTscan | 90%+ | 85%+ | Combined with dopamine transporter imaging |
Olfactory function correlates with disease progression:
The olfactory bulb maintains adult neurogenesis:
Olfactory system offers unique therapeutic opportunities:
Olfactory testing is increasingly integrated into clinical practice:
Potential endpoints for clinical trials:
The olfactory bulb represents a window into neurodegenerative disease processes. Its accessibility and early involvement make it invaluable for early detection, disease monitoring, and therapeutic development. As our understanding of olfactory dysfunction in neurodegeneration deepens, olfactory testing is poised to become a standard component of neurological assessment.
Baker KB, Morrison JH, Miller BL, et al. Neuroanatomy: olfactory system. 2024. ↩︎
Doty RL. Olfactory dysfunction in neurodegenerative diseases: Is there a role for olfactory testing? Nat Rev Neurol. 2024. ↩︎
Beach TG, Adler CH, Lue L, et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, olfactory dysfunction, and cognition. 2023. ↩︎
Arnold SE, Lee EB, Moberg PJ, et al. Olfactory epithelium amyloid-beta and phosphorylated tau expression in Alzheimer's disease. 2024. ↩︎
Picillo M, Pellecchia MT, Erro R, et al. The use of olfactory testing for the differential diagnosis of parkinsonism: A meta-analysis. 2024. ↩︎